{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:44:07Z","timestamp":1794411847311,"version":"4.9.0"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1370,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1473-2165.2011.00590.x","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T08:02:22Z","timestamp":1323331342000},"page":"324-329","source":"Crossref","is-referenced-by-count":47,"title":["Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products"],"prefix":"10.1111","volume":"10","author":[{"given":"David W","family":"Osborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,8]]},"reference":[{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB1|cit1","unstructured":"Lipid Excipients for Topical Drug Delivery http:\/\/www.gattefosse.com\/media\/document\/lipid_excipients_for_topical_drug_delivery.pdf"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB2|cit2","unstructured":"USP-NF National Formulary 29th edition monograph entitled Diethylene Glycol Monoethyl Ether United States Pharmacopeial Convention"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB3|cit3","unstructured":"EWG\u2019s Skin Deep Cosmetics Database http:\/\/www.ewg.org\/skindeep\/ingredient\/702287\/ETHOXYDIGLYCOL\/"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB4|cit4","unstructured":"Scientific Committee on Consumer Products (SCCP) 2006 Opinion on diethylene glycol monoethyl ether (DEGEE) http:\/\/ec.europa.eu\/health\/ph_risk\/committees\/04_sccp\/docs\/sccp_o_082.pdf"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB5|cit5","volume-title":"Aczone [package insert]","year":"2009"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB6|cit6","unstructured":"Osborne DW Protectant for UV-induced skin damage"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB7|cit7","first-page":"135","volume-title":"Dermal Absorption Models in Toxicology and Pharmacology","author":"Walters","year":"2006"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB8|cit8","volume-title":"Nothing is Without Poison","author":"Roberts","year":"2002"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0190-9622(99)70260-4","article-title":"A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis","volume":"41","author":"Kaminester","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB10|cit10","unstructured":"Osborne DW Composition and methods for topical application of therapeutic agents"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB11|cit11","unstructured":"Osborne DW Composition and methods for topical application of therapeutic agents"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.addr.2011.01.012","article-title":"Nanoparticles and microparticles for skin drug delivery","volume":"63","author":"Prow","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-5173(94)00143-X","article-title":"Effects of some non-toxic penetration enhancers on in vitro heparin skin permeation from gel vehicles","volume":"111","author":"Bonina","year":"1994","journal-title":"Int J Pharm"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(01)00806-7","article-title":"Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations","volume":"228","author":"Puglia","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0939-6411(01)00215-6","article-title":"Influence of Transcutol CG on the skin accumulation and transdermal permeation of ultraviolet absorbers","volume":"53","author":"Godwin","year":"2002","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000159265","article-title":"Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients","volume":"21","author":"Otto","year":"2008","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.2042-7158.1991.tb03548.x","article-title":"Development and evaluation of an intracutaneous depot formulation of corticosteroids using transcutol as a cosolvent: in vitro, ex vivo and in vivo rat studies","volume":"43","author":"Panchagnula","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000107575","article-title":"Percutaneous penetration enhancers: an overview","volume":"20","author":"Thong","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.colsurfb.2010.09.015","article-title":"Enhancing percutaneous delivery of methotrexate using different types of surfactants","volume":"82","author":"Javadzadeh","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2005.12.029","article-title":"Effect of vehicles and enhancers on the topical delivery of cyclosporine A","volume":"311","author":"Liu","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2006.10.005","article-title":"Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% (Aczone) for the treatment of acne vulgaris","volume":"56","author":"Draelos","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB22|cit22","volume-title":"Differn 0.1% Cream [package insert]","year":"2004"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB23|cit23","volume-title":"Differn 0.3% Gel [package insert]","year":"2007"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB24|cit24","volume-title":"Ziana [package insert]","year":"2009"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB25|cit25","volume-title":"Benzaclin [package insert]","year":"2010"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB26|cit26","volume-title":"Clindagel [package insert]","year":"2007"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB27|cit27","unstructured":"Inactive Ingredient Search for Approved Drug Products http:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/getiigWEB.cfm"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB28|cit28","first-page":"300","article-title":"Development of the antimicrobial effectiveness test as USP Chapter <51>","volume":"6","author":"Sutton","year":"2002","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB29|cit29","unstructured":"Godowski KC Dunham J Osborne DW Anti- P.\u00a0acnes activity of proguanil"},{"key":"10.1111\/j.1473-2165.2011.00590.x-BIB30|cit30","first-page":"69","volume-title":"Topical Drug Delivery Formulations","author":"Osborne","year":"1990"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2011.00590.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1473-2165.2011.00590.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:34:26Z","timestamp":1625549666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2011.00590.x"}},"subtitle":["DEGEE: an emerging solvent"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2011.00590.x","relation":{},"ISSN":["1473-2130"],"issn-type":[{"value":"1473-2130","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}